Azacitidine in untreated acute myeloid leukemia: A report on 149 patients von Thépot, Sylvain, Itzykson, Raphael, Seegers, Valerie, Recher, Christian, Raffoux, Emmanuel, Quesnel, Bruno, Delaunay, Jacques, Cluzeau, Thomas, Marfaing Koka, Anne, Stamatoullas, Aspasia, Chaury, Marie‐Pierre, Dartigeas, Caroline, Cheze, Stéphane, Banos, Anne, Morel, Pierre, Plantier, Isabelle, Taksin, Anne‐Laure, Marolleau, Jean Pierre, Pautas, Cecile, Thomas, Xavier, Isnard, Francoise, Beve, Blandine, Chait, Yasmine, Guerci, Agnes, Vey, Norbert, Dreyfus, Francois, Ades, Lionel, Ifrah, Norbert, Dombret, Herve, Fenaux, Pierre, Gardin, Claude

Volltext

Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM von Natarajan-Amé, Shanti, Park, Sophie, Ades, Lionel, Vey, Norbert, Guerci-Bresler, Agnès, Cahn, Jean-Yves, Etienne, Gabriel, Bordessoule, Dominique, Ravoet, Christophe, Legros, Laurence, Cheze, Stephane, Stamatoullas, Aspasia, Berger, Elisabeth, Schmidt, Aline, Charbonnier, Aude, Chaury, Marie-Pierre, Braun, Thorsten, Fenaux, Pierre, Dreyfus, Francois

Volltext

Early introduction of ESA in low risk MDS patients may delay the need for RBC transfusion: A retrospective analysis on 112 patients von Park, Sophie, Kelaidi, Charikleia, Sapena, Rosa, Vassilieff, Dominique, Beyne-Rauzy, Odile, Coiteux, Valérie, Vey, Norbert, Ravoet, Christophe, Cheze, Stéphane, Rose, Christian, Legros, Laurence, Stamatoullas, Aspasia, Escoffre-Barbe, Martine, Guerci, Agnès, Chaury, Marie-Pierre, Fenaux, Pierre, Dreyfus, François

Volltext

A simple method for detection of major phenotypic abnormalities in myelodysplastic syndromes: expression of CD56 in CMML von Lacronique-Gazaille, Charlotte, Chaury, Marie-Pierre, Le Guyader, Alexandre, Faucher, Jean-Luc, Bordessoule, Dominique, Feuillard, Jean

Volltext

Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM von Rose, Christian, Brechignac, Sabine, Vassilief, Dominique, Pascal, Laurent, Stamatoullas, Aspasia, Guerci, Agnes, Larbaa, Dalila, Dreyfus, François, Beyne-Rauzy, Odile, Chaury, Marie Pierre, Roy, Lydie, Cheze, Stephane, Morel, Pierre, Fenaux, Pierre

Volltext

Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study von Adès, Lionel, Boehrer, Simone, Prebet, Thomas, Beyne-Rauzy, Odile, Legros, Laurence, Ravoet, Christophe, Dreyfus, François, Stamatoullas, Aspasia, Pierre Chaury, Marie, Delaunay, Jacques, Laurent, Guy, Vey, Norbert, Burcheri, Sara, Mbida, Rose-Marie, Hoarau, Natacha, Gardin, Claude, Fenaux, Pierre

Volltext

A randomized phase II trial of azacitidine +/- epoetin-β in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents von Thépot, Sylvain, Ben Abdelali, Raouf, Chevret, Sylvie, Renneville, Aline, Beyne-Rauzy, Odile, Prébet, Thomas, Park, Sophie, Stamatoullas, Aspasia, Guerci-Bresler, Agnes, Cheze, Stéphane, Tertian, Gérard, Choufi, Bachra, Legros, Laurence, Bastié, Jean Noel, Delaunay, Jacques, Chaury, Marie Pierre, Sanhes, Laurence, Wattel, Eric, Dreyfus, Francois, Vey, Norbert, Chermat, Fatiha, Preudhomme, Claude, Fenaux, Pierre, Gardin, Claude

Volltext

Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup von Petit, B, Chaury, MP, Le Clorennec, C, Jaccard, A, Gachard, N, Moalic-Judge, S, Labrousse, F, Cogne, M, Bordessoule, D, Feuillard, J

Volltext

Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction von Ramos, F, Thépot, S, Pleyer, L, Maurillo, L, Itzykson, R, Bargay, J, Stauder, R, Venditti, A, Seegers, V, Martínez-Robles, V, Burgstaller, S, Récher, C, Debén, G, Gaidano, G, Gardin, C, Musto, P, Greil, R, Sánchez-Guijo, F, Fenaux, P

Volltext

High Response Rate and Improved Exercise Capacity and Quality of Life with a New Regimen of Darbepoetin Alfa (DAR) +/−G-CSF in Lower-Risk MDS : a Phase II Study von Kelaidi, Charikleia, Beyne-Rauzy, Odile, Braun, Thorsten, Cougoul, Pierre, Ades, Lionel, Pillard, Fabien, Lamberto, Christine, Jernival, Tony, Mortera, Edith, Guerci, Agnes, Choufi, B., Stamatoullas, Aspasia, Slama, Borhane, De Renzis, Benoît, Ame, S., Ghandi, Damaj, Boyer, Françoise, Chaury, Marie-Pierre, Legros, Laurence, Cheze, Stéphane, Testu, Anna, Gyan, Emmanuel, Bene, Marie C, Rose, Christian, Dreyfus, Francois, Fenaux, Pierre

Volltext

Quantification of MDM2 Gene Expression Level by RQ-PCR Is Predictive of the First Complete Remission in Adulte Acute Myeloid Leukaemia von Gachard, Nathalie, Turlure, Pascal, Trimoreau, Franck, Moreau, Stephane, Donnard, Magali, Chaury, Marie-Pierre, Pradeau, Rachel, Bordessoule, Dominique, Feuillard, Jean

Volltext